RenovoRx, Inc. (RNXT)
| Market Cap | 36.52M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -4.31M |
| Shares Out | 8.91M |
| EPS (ttm) | -1.48 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 48,281 |
| Open | 3.99 |
| Previous Close | 4.06 |
| Day's Range | 3.90 - 4.19 |
| 52-Week Range | 3.81 - 16.74 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 15.50 (+278.0%) |
| Earnings Date | n/a |
About RNXT
RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for our lead product candidate RenovoGem. Our therapy platform, RenovoTAMP, combines our patented FDA cleared delivery system, RenovoCath®, with small molecule chemotherapeutic agents that can be forced across the vessel wall using pressure, targeting these anti-cancer drugs locally to the solid tumors. While we anticipate investigating other chemotherapeutic agents for int...
Financial Performance
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for RenovoRx stock is "Buy." The 12-month stock price forecast is 15.50, which is an increase of 278.05% from the latest price.
News
RenovoRx to Present at the H.C. Wainwright Bioconnect Virtual Conference
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (NASDAQ: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced that Shaun Bagai, Chief Executive Officer, will p...
5 Short Squeeze Candidates To Watch: Pioneer Power, NuZee Remain At The Top, Grab Rejoins The Leaderboard
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) are two high-profile ex...
Short Squeeze Stocks: PPSI, NUZE and 3 Others Experts Think Are Ready to Pop
PPSI, NUZE, and three other stocks are ranked highly in Fintel's Short Squeeze Screener. All three names have a score higher than 96.
5 Short Squeeze Candidates To Watch: Pioneer Power Tops List Along With Newegg, Nuzee And More
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE: GME) and AMC Entertainment Holdings (NYSE: AMC) are two high-profile ...
RenovoRx Announces Third Quarter 2021 Financial Results
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today reported its unaudited financial results for the third quar...
RenovoRx Announces Presentation of Final Data from RR2 Observational Registry Study at 2021 Pancreas Club Annual Meeting
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced that it will be presenting an ePoster at the 2021...
RNXT Stock Alert: 5 Things to Know as RenovoRx Soars 100%+ Today
RenovoRx (RNXT) stock is rocketing higher today thanks to a presentation of data at a medical conference yesterday evening. The post RNXT Stock Alert: 5 Things to Know as RenovoRx Soars 100%+ Today appe...
Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy...
MIAMI & LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced its novel therapy platform, RenovoTAMPTM ...
RNXT Stock: The FDA News That Has Biotech Company RenovoRx Rocketing Higher Today
RenovoRx (RNXT) stock is running higher on Tuesday following news that the U.S. Food and Drug Administration granted it new 501(k) clearance. The post RNXT Stock: The FDA News That Has Biotech Company R...
See Why RenovoRx Stock Is Shooting Higher On Tuesday
The FDA has granted a new 510(k) clearance to RenovoRx Inc's (NASDAQ:RNXT) RenovoCath Delivery System. The RenovoCath Delivery System is the device component of the Company's initial product, RenovoGem.
RenovoRx Receives New 510(k) Clearance for its RenovoCath® Delivery System Designed for Targeted Treatment of Solid T...
LOS ALTOS, Calif., Sept. 7, 2021 /PRNewswire/ -- RenovoRx , Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced it has received a new 510(k) clear...